Agilus Diagnostics Launches India’s Most Comprehensive Vital Shape Test Suite for Obesity and Metabolic Health

▴ Agilus Diagnostics
Agilus Diagnostics, one of India’s leading diagnostic service providers and a subsidiary of Fortis Healthcare Ltd., today announced the launch of the Complete Care Vital Shape test suite (Lite, Core, and Ultra).

National, December 04, 2025: Agilus Diagnostics, one of India’s leading diagnostic service providers and a subsidiary of Fortis Healthcare Ltd., today announced the launch of the Complete Care Vital Shape test suite (Lite, Core, and Ultra). This structured portfolio is designed for smarter weight management, early detection of insulin resistance, and long-term metabolic health monitoring — especially relevant amid rising global attention on GLP-1–based therapies for obesity.

 

India continues to witness a steep rise in obesity, with nearly one in four females and two in five males now overweight or obese. In urban populations, prevalence has reached 30–40%, driven by lifestyle and dietary changes. This growing burden underscores the need for comprehensive diagnostics that support prevention, guide clinical decision-making, and monitor long-term metabolic risks.

 

About the Vital Shape Suite
The Vital Shape panels offer tiered depth of assessment to detect metabolic and obesity-related risks early:

  • Vital Shape Lite (72 parameters): Provides a strong baseline metabolic evaluation, including BMI, Comprehensive Metabolic Profile (CMP), eGFR for kidney health, CBC, lipid profile, free thyroid profile, HbA1c, fasting insulin, HOMA-IR for insulin resistance, FIB-4 for liver health, ferritin and iron studies for anemia, along with Vitamin D and Vitamin B12 status.
  • Vital Shape Core (80 parameters): Includes all Lite parameters, plus deeper insights through hsCRP (cardiac inflammation), and additional markers of nutritional and metabolic health.
  • Vital Shape Ultra (86 parameters): One of India’s most comprehensive obesity-focused test suites, adding leptin and adiponectin (metabolic signalling), amylase and lipase (pancreatitis risk), and PTH with calcium (bone and endocrine function), offering advanced insights into fatty liver, chronic inflammation and hormonal drivers of metabolic dysfunction.

 

Dr. Anand K, Managing Director & CEO, Agilus Diagnostics, said: “We are witnessing a global shift in obesity care, especially with the increasing use of GLP-1–based therapies. As clinical practices evolve, diagnostics must evolve with them. Complete Care Vital Shape empowers clinicians with comprehensive insights into insulin resistance, fatty liver, metabolic syndrome and cardiometabolic disorders. These conditions that lead to obesity often remain silent for years, and early detection is crucial for preventive and personalised care. This suite reinforces our commitment to supporting evidence-based decision-making at a time when patient expectations and scientific guidance are rapidly changing.”

 

Dr. Ajay Phadke, Director – Strategic Business Development, Agilus Diagnostics, added: “Over the last quarter, we have seen a sharp rise in enquiries for structured assessments around obesity management, high-insulin states and metabolic dysfunction. Complete Care Vital Shape positions Agilus among the select few offering such detailed, clinically oriented panels in this space. As the use of GLP-1 agonists increases, clinicians need deeper baseline evaluations and continuous monitoring to track metabolic risks — from fatty liver to cardiometabolic disorders. This suite is built precisely for those needs, and we will continue expanding the portfolio based on real-world evidence and clinical utility.”

 

As GLP-1 medications gain mainstream acceptance in obesity management, clinicians worldwide are underscoring the importance of baseline metabolic evaluations, ongoing monitoring, and early detection of risks before, during, and after therapy. With one of the world’s largest populations at risk for diabetes, cardiovascular disease, and fatty liver, India stands to benefit significantly from standardised diagnostic protocols. The Complete Care Vital Shape suite has been designed to support this emerging clinical need of setting the baseline for glp1 therapy and periodic monitoring for managing the efficacy.

Tags : #

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Smart Operating Rooms: The Future of Hospital OTNovember 21, 2026
Smartphone Diagnostics: Phones as Medical Screening ToolsNovember 21, 2026
AI-Enabled Endoscopy: Can It Detect More Than the Human Eye?November 20, 2026
AI-Enabled Endoscopy: Can It Detect More Than the Human Eye?November 20, 2026
Hospital-at-Home in India: Can Technology Deliver Safe Care?November 20, 2026
Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026